{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:39:32Z","timestamp":1793414372617,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015678","name":"Einstein Centrum f\u00fcr Regenerartive Therapien, Charit\u00e9-Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG-SFB-TR36-project A3"],"award-info":[{"award-number":["DFG-SFB-TR36-project A3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ymthe.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T03:21:30Z","timestamp":1599535290000},"page":"32-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients"],"prefix":"10.1016","volume":"29","author":[{"given":"Leila","family":"Amini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios Laurin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Zarrinrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Felicitas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e Jacqueline","family":"Wendering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-9179","authenticated-orcid":false,"given":"Michael","family":"Schmueck-Henneresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.09.011_bib1","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.transproceed.2005.11.036","article-title":"The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection","volume":"37","author":"Chen","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ymthe.2020.09.011_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00007890-200208270-00026","article-title":"The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation","volume":"74","author":"Tong","year":"2002","journal-title":"Transplantation"},{"issue":"5, Suppl","key":"10.1016\/j.ymthe.2020.09.011_bib3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/TP.0b013e3182481347","article-title":"Infections and organ transplantation: new challenges for prevention and treatment--a colloquium","volume":"93","author":"Grossi","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2020.09.011_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jmv.23539","article-title":"High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy","volume":"85","author":"Harvala","year":"2013","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/TP.0000000000001825","article-title":"CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor","volume":"101","author":"Schachtner","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2020.09.011_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-6143.2009.02872.x","article-title":"Successful immunotherapy of HCMV disease using virus-specific T\u00a0cells expanded from an allogeneic stem cell transplant recipient","volume":"10","author":"Hill","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbmt.2013.01.021","volume":"19","author":"Clancy","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2013-12-547349","article-title":"Lowest numbers of primary CD8(+) T\u00a0cells can reconstitute protective immunity upon adoptive immunotherapy","volume":"124","author":"Stemberger","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/tid.12435","article-title":"Combination therapy for multidrug-resistant cytomegalovirus disease","volume":"17","author":"Stuehler","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T\u00a0cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2020.09.011_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T\u00a0cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.09.011_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/CJI.0b013e3181b88fda","article-title":"Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy","volume":"32","author":"Brestrich","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2020.09.011_bib14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3389\/fimmu.2019.01148","article-title":"Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients","volume":"10","author":"Amini","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/ajt.13023","article-title":"Adoptive T\u00a0cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipient","volume":"15","author":"Macesic","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib16","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/cti.2015.5","article-title":"Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation","volume":"4","author":"Holmes-Liew","year":"2015","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.ymthe.2020.09.011_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/cid\/ciy549","article-title":"Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: A single-arm open-label phase I clinical trial","volume":"68","author":"Smith","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.09.011_bib18","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T\u00a0cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1600-6143.2009.02672.x","article-title":"Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy","volume":"9","author":"Brestrich","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1600-6143.2010.03413.x","article-title":"Mycophenolic acid-mediated suppression of human CD4+ T\u00a0cells: more than mere guanine nucleotide deprivation","volume":"11","author":"He","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ymthe.2020.09.011_bib23","doi-asserted-by":"crossref","first-page":"e31465","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin inhibitors suppress cytokine production from memory T\u00a0cells and differentiation of na\u00efve T\u00a0cells into cytokine-producing mature T\u00a0cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.4049\/jimmunol.155.7.3322","article-title":"Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T\u00a0cells generated from CD45RO- and CD45RO+ subsets","volume":"155","author":"Brinkmann","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","article-title":"Glucocorticoids in T\u00a0cell apoptosis and function","volume":"63","author":"Herold","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2020.09.011_bib26","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/blood-2009-07-228387","article-title":"Generation of EBV-specific cytotoxic T\u00a0cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease","volume":"114","author":"Brewin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib27","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1111\/ajt.12475","article-title":"Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy","volume":"13","author":"Ricciardelli","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib28","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1182\/blood-2009-07-230482","article-title":"Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)","volume":"114","author":"De Angelis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib29","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/00007890-200206150-00023","article-title":"FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506","volume":"73","author":"Xu","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2020.09.011_bib30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.celrep.2016.09.092","article-title":"Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR\/Cas9","volume":"17","author":"Gundry","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2020.09.011_bib31","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.4049\/jimmunol.1103763","article-title":"Preferential expansion of human virus-specific multifunctional central memory T\u00a0cells by partial targeting of the IL-2 receptor signaling pathway: the key role of CD4+ T\u00a0cells","volume":"188","author":"Schmueck","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib32","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: A Web-based Tool for Identifying and Validating CRISPR\/Cas Off-target Sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"D1","key":"10.1016\/j.ymthe.2020.09.011_bib33","doi-asserted-by":"crossref","first-page":"D762","DOI":"10.1093\/nar\/gkx1020","article-title":"The UCSC Genome Browser database: 2018 update","volume":"46","author":"Casper","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2020.09.011_bib34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib35","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ki.2015.215","article-title":"A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients","volume":"88","author":"Weist","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2020.09.011_bib36","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T\u00a0cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CJI.0b013e31827b87cc","article-title":"HCMV-specific T-cell therapy: do not forget supply of help","volume":"36","author":"Hammoud","year":"2013","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2020.09.011_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jim.2003.10.017","article-title":"The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in\u00a0vitro and in\u00a0vivo","volume":"285","author":"Hermans","year":"2004","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2020.09.011_bib39","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T\u00a0cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib40","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/IAI.01367-06","article-title":"In\u00a0vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis","volume":"75","author":"Arce","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2020.09.011_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2013-02-483586","article-title":"CD40L expression permits CD8+ T\u00a0cells to execute immunologic helper functions","volume":"122","author":"Frentsch","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib42","doi-asserted-by":"crossref","first-page":"e13601","DOI":"10.1111\/petr.13601","article-title":"CD154-expressing CMV-specific T\u00a0cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation","volume":"24","author":"Ashokkumar","year":"2020","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of Streptococcus pyogenes Cas9-reactive T\u00a0cells within the adult human population","volume":"25","author":"Wagner","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.09.011_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.09.011_bib45","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ymthe.2020.06.002","article-title":"CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation","volume":"28","author":"Kaeuferle","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.09.011_bib46","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/bloodadvances.2020001977","article-title":"Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T\u00a0cells","volume":"4","author":"Basar","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2020.09.011_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2002.01777.x","article-title":"Induction of apoptosis and modulation of activation and effector function in T\u00a0cells by immunosuppressive drugs","volume":"128","author":"Strauss","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib48","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/00007890-200109270-00017","article-title":"Generation of autologous Epstein-Barr virus-specific cytotoxic T\u00a0cells for adoptive immunotherapy in solid organ transplant recipients","volume":"72","author":"Savoldo","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2020.09.011_bib49","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1084\/jem.190.9.1297","article-title":"Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers","volume":"190","author":"Zhang","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2020.09.011_bib50","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2003-01-0183","article-title":"IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T\u00a0cells in\u00a0vitro","volume":"102","author":"Alves","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.09.011_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-2478(00)00160-7","article-title":"Involvement of FK506-sensitive and insensitive granule exocytosis pathways in perforin-dependent target cell lysis mediated by a CD8+ CTL clone","volume":"72","author":"Kataoka","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ymthe.2020.09.011_bib52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z","article-title":"Induction of interferon-\u03b3 production in Th1 CD4+ T\u00a0cells: evidence for two distinct pathways for promoter activation","volume":"29","author":"Yang","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2010.07.004","article-title":"Modular utilization of distal cis-regulatory elements controls Ifng gene expression in T\u00a0cells activated by distinct stimuli","volume":"33","author":"Balasubramani","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2020.09.011_bib54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3640","article-title":"Recruitment of calcineurin to the TCR positively regulates T\u00a0cell activation","volume":"18","author":"Dutta","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.180.2.763","article-title":"Calcineurin mediates human tumor necrosis factor alpha gene induction in stimulated T and B cells","volume":"180","author":"Goldfeld","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2020.09.011_bib56","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/357692a0","article-title":"FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin","volume":"357","author":"O\u2019Keefe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.09.011_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201504-0733OC","article-title":"Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation","volume":"193","author":"Snyder","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl 10","key":"10.1016\/j.ymthe.2020.09.011_bib58","first-page":"51","article-title":"Cytomegalovirus","volume":"4","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymthe.2020.09.011_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0404.2008.01090.x","article-title":"Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis","volume":"119","author":"Braitch","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ymthe.2020.09.011_bib60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.phrs.2011.01.005","article-title":"Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK\/PD relationships","volume":"63","author":"Pr\u00e9maud","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymthe.2020.09.011_bib61","doi-asserted-by":"crossref","first-page":"19896","DOI":"10.1074\/jbc.RA119.010379","article-title":"Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T\u00a0cells","volume":"294","author":"Maeda","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.09.011_bib62","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s000180050403","article-title":"Dexamethasone enhances CTLA-4 expression during T\u00a0cell activation","volume":"55","author":"Xia","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2020.09.011_bib63","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.179.6.3831","article-title":"Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter","volume":"179","author":"Gibson","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib64","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nm0296-216","article-title":"T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients","volume":"2","author":"Riddell","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.09.011_bib65","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib66","article-title":"Inference of CRISPR Edits from Sanger Trace Data","author":"Hsiau","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2020.09.011_bib67","article-title":"Quantitative Evaluation of Chromosomal Rearrangements in Primary Gene-Edited Human Stem Cells by Preclinical CAST-Seq","author":"Turchiano","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2020.09.011_bib68","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nmeth.4284","article-title":"Mapping the genomic landscape of CRISPR-Cas9 cleavage","volume":"14","author":"Cameron","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2020.09.011_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tibtech.2018.06.005","article-title":"The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?","volume":"37","author":"Cathomen","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10522-015-9563-2","article-title":"Impact of age, sex and CMV-infection on peripheral T\u00a0cell phenotypes: results from the Berlin BASE-II Study","volume":"16","author":"Di Benedetto","year":"2015","journal-title":"Biogerontology"},{"key":"10.1016\/j.ymthe.2020.09.011_bib71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.1601494","article-title":"Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells","volume":"199","author":"Schmueck-Henneresse","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib72","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.4049\/jimmunol.1402090","article-title":"Peripheral blood-derived virus-specific memory stem T\u00a0cells mature to functional effector memory subsets with self-renewal potency","volume":"194","author":"Schmueck-Henneresse","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib73","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T\u00a0cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.09.011_bib74","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.09.011_bib75","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt.2661","article-title":"Heritable gene targeting in the mouse and rat using a CRISPR-Cas system","volume":"31","author":"Li","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.09.011_bib76","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V100.5.1755.h81702001755_1755_1764","article-title":"B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T\u00a0cells","volume":"100","author":"Moosmann","year":"2002","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620304688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620304688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:31:33Z","timestamp":1791995493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620304688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1525001620304688"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}